| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.038 | 0.8 |